Orange : Attractive timing to go long again
Entry price | Target | Stop-loss | Potential |
---|
€10.77 |
€11.9 |
€10.2 |
+10.54% |
---|
The Orange share is coming back to a technical support zone comprising the lower bound of the trading range. This provides a good timing to go long on the stock.
Summary● In a short-term perspective, the company has interesting fundamentals.
Strengths● With a P/E ratio at 9.99 for the current year and 9.69 for next year, earnings multiples are highly attractive compared with competitors.
● The company is one of the best yield companies with high dividend expectations.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses● With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
● The company is in debt and has limited leeway for investment
● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 12.09 EUR
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.